Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone. Issue 1 (31st December 2021)

• Record Type: Journal Article
• Authors: Robbe-Saule, Marie; Foulon, Mélanie; Poncin, Isabelle; Esnault, Lucille; Varet, Hugo; Legendre, Rachel; Besnard, Alban; Grzegorzewicz, Anna E.; Jackson, Mary; Canaan, Stéphane; Marsollier, Laurent; Marion, Estelle
• Is Part Of: Virulence. Volume 12:Issue 1(2021)
• Page Start: 1438
• Page End: 1451
• Publication Date: 2021-12-31
• Subjects: Mycobacterium ulcerans -- host-bacterium interaction -- mycolactone -- rna-sequencing -- metabolism; Virulence (Microbiology) -- Periodicals; Bacterial diseases -- Periodicals; Molecular microbiology -- Periodicals; 579.05
• DOI: 10.1080/21505594.2021.1929749
• Languages: English
• ISSNs: 2150-5608

Abstract

ABSTRACT: Mycobacterium ulcerans is the causal agent of Buruli ulcer, a chronic infectious disease and the third most common mycobacterial disease worldwide. Without early treatment, M. ulcerans provokes massive skin ulcers, caused by the mycolactone toxin, its main virulence factor. However, spontaneous healing may occur in Buruli ulcer patients several months or years after the disease onset. We have shown, in an original mouse model, that bacterial load remains high and viable in spontaneously healed tissues, with a switch of M. ulcerans to low levels of mycolactone production, adapting its strategy to survive in such a hostile environment. This original model offers the possibility to investigate the regulation of mycolactone production, by using an RNA-seq strategy to study bacterial adaptation during mouse infection. Pathway analysis and characterization of the tissue environment showed that the bacillus adapted to its new environment by modifying its metabolic activity and switching nutrient sources. Thus, M. ulcerans ensures its survival in healing tissues by reducing its secondary metabolism, leading to an inhibition of mycolactone synthesis. These findings shed new light on mycolactone regulation and pave the way for new therapeutic strategies.